VYOME HOLDINGS, INC. Contract Liability (Deferred Revenue)
VYOME HOLDINGS, INC. (HIND) had Contract Liability (Deferred Revenue) of $61.00 thousand as of 2020-09-30, per its 10-Q filed 2020-11-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Deferred Revenue, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2021-03-12
- 2020-09-30: Contract with Customer, Liability, Current $61.00K.
- 2020-06-30: Contract with Customer, Liability, Current $123.00K.
- 2020-03-31: Contract with Customer, Liability, Current $462.00K.
- 2019-12-31: Contract with Customer, Liability, Current $424.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2020-09-30 | $61.00K 10-Q · filed 2020-11-06 |
| 2020-06-30 | $123.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $462.00K 10-Q · filed 2020-06-19 |
| 2019-12-31 | $424.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | $283.00K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $320.00K 10-Q · filed 2019-07-24 |
| 2019-03-31 | $370.00K 10-Q · filed 2019-05-10 |
| 2018-12-31 | $352.00K 10-K · filed 2020-02-27 |
| 2018-09-30 | $301.00K 10-Q · filed 2018-11-02 |
| 2018-06-30 | $302.00K 10-Q · filed 2018-08-02 |
| 2017-12-31 | $510.00K 10-Q · filed 2018-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |